• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Sanofi

Union Square in San Francisco during JPM 2026
Biotech

JPM26: Sanofi looks ahead to lingering US policy hurdles

Though many challenges from the Trump admin have been addressed, Sanofi still has to settle scrutiny of its vaccines and an unexpected FDA rejection.
Darren Incorvaia Jan 14, 2026 2:28pm
obesity drugs GLP-1 GLP-1s incretin medicine weight loss weight loss drugs

Alveus emerges to tackle obesity drug pitfalls with $160M

Jan 8, 2026 7:30am
Bishop chess chess bishop diagonal chessboard

Series B round of $125M will fund Diagonal's move into clinic

Jan 8, 2026 6:30am
Three blocks displaying from left to right a person a handshake and another person

InduPro nabs 2nd Big Pharma deal with $950M Lilly pact

Jan 7, 2026 3:52pm
An envelope with rejected mark Vector illustration

FDA shares CRL for Sanofi MS drug mere weeks after rebuff

Jan 6, 2026 4:30am
Sanofi

Sanofi's 2nd autoimmune pact with AI biotech could reach $2.5B

Jan 5, 2026 7:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings